NCT05439603 ANC-501 in the Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT05437588 Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents Status RECRUITING Phase NA
NCT05435820 Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With Laser Status COMPLETED Phase NA
NCT05435222 Evaluation of a Male-specific Psychotherapeutic Program for Major Depressive Disorders Status RECRUITING Phase NA
NCT05434156 ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05431374 Measurement-Based Care Vs. Standard Care for Major Depressive Disorder Status COMPLETED Phase NA
NCT05427981 Anti-suicidal Effects of Buprenorphine In Depressed Individuals Status WITHDRAWN Phase PHASE3
NCT05426265 The Effects of Videogames on Depression Symptoms and Brain Dynamics Status COMPLETED Phase NA
NCT05425290 Emotion Regulation Training to Reduce Cardiovascular Disease Risk Among Depressed Young Adults in Southern Mississippi Status COMPLETED Phase NA
NCT05422417 Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression Status RECRUITING Phase NA
NCT05411302 Augmenting Mental Health Support Through a Supportive Text Messaging Program Status RECRUITING Phase NA
NCT05400785 Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning Status COMPLETED Phase NA
NCT05399498 Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder Status COMPLETED Phase PHASE2
NCT05385783 A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder Status COMPLETED Phase PHASE1/PHASE2